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Distributed Drug Discovery (D3) is a multidisciplinary approach to identifying molecules that exhibit 
activity in the treatment of neglected diseases such as malaria, leishmaniasis, and tuberculosis as well as 
recalcitrant cystic fibrosis (CF) airway infections. D3 seeks to accomplish this task by combining 
computational chemistry, synthetic chemistry, and biological screening all within an educational 
framework. Recent reports suggest that D-amino acids are effective in the disassembly and inhibition of 
bacterial biofilms, which are important for a number of bacterial infections, including those in the CF 
lung. Utilizing chemical drawing software, we constructed (enumerated) target phenylalanine derivatives 
from commercially available benzyl halides by substitution at the α position of an amino acid scaffold. A 
subset of these enumerated molecules was computationally selected for synthesis based on chemical 
properties. These compounds were synthesized using simple, solid-phase techniques in an undergraduate 
organic chemistry laboratory class. The resulting racemic unnatural amino acid derivatives were then 
screened for activity in a biofilm assay.  The results show biofilm inhibition with synthesized 
phenylalanine derivatives. Analysis of the results reveals a trend between lipophilicity and the degree of 
biofilm inhibition. These new molecules may lead to an avenue for therapy for those CF individuals 
suffering with bacterial lung infection. As a part of the undergraduate curriculum, this work provides the 
first example of D3-linked undergraduate student computational analysis, synthesis, and biological 
evaluation. 
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